Correlation results between plasma homocysteine, metabolic syndrome components and cardiovascular risk markers in 2045 french military subjects: EPIMIL cohort;Homocystéine et paramètres du syndrome métabolique et du risque cardiovasculaire chez 2045 militaires: Étude EPIMIL

Immuno-Analyse et Biologie Specialisee

Volumn 20, Issue 3, 2005, Pages 169-172

  Chellak, S ^a   Bigaillon, C ^a   El Jahiri, Y ^a   Garcia, C ^a   Ceppa, F ^a   Mayaudon, H ^a   Dupuy, O ^a   Garcin, J M ^a   Baigts, F ^a   Bauduceau, B ^a   Burnat, P ^a  

^a SERVICE D ENDOCRINOLOGIE   (France)

Author keywords

Cardiovascular risk; EPIMIL cohort; Homocysteine; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; FATTY ACID; HOMOCYSTEINE; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ARMY; ARTICLE; AUTOMATION; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; FOLLOW UP; FRANCE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

EID: 20444367243     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2005.03.002     Document Type: Article

References (13)

1. B. Bauduceau, F. Baigts, H. Mayaudon, P. Burnat, F. Ceppa, and O. Dupuy Les premiers ŕsultats d'EPIMIL:: ́tude ́pid́miologique des facteurs de risque et du syndrome ḿtabolique en milieu militaire Diabetes Metab. 30 2004 1S9 1S28
2. M. Buysschaert, A.S. Dramais, P.E. Wallemacq, and M.P. Hermans Hyperhomocysteinemia in type 2 diabetes Diabetes Care 12 2000 1816 1822
3. M. Cattaneo Hyrehomocyst́ińmie et thrombose J. Dade Behring Juin 2003 14 16
4. Conri C, Constans J, Parrot F, Skopinski S, Cipriano C. Homocystéinémie : rôle en pathologie vasculaire 2000; 13: 737-741.
5. I. Drouillard, F. Adam, F. Zagnoli, D. Chianea, and H. Corbe Homocyst́ine:; un nouveau facteur de risque cardiovasculaire:? Connaissances actuelles et mise au point d'une technique de dosage au laboratoire Feuill. Biol. 222 1998 47 52
6. A.V. Fonseca, L.M. Fink, and P.A. Kern Insulin sensitivity and plasma homocysteine concentrations in non diabetic and normal weight subjects Atherosclerosis 167 2003 105 109
7. S. Gallistl, K. Sudi, H. Mangge, W. Erwa, and M. Borkenstein Insulin is an independant correlate of plasma homocyst́ine levels in obese children and adolescents Diabetes Care 9 2000 1348 1352
8. J.M. Garcin, A. Abouzahir, C. Bredin, L. Bonnevie, J.A. Bronstein, and L. Bordier Diab̀te et hyperhomocyst́ińmie DRF 83 2004 52 60
9. I.F. Godsland, J.R. Rosankiewicz, A.J. Proudler, and D.G. Johnston Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men J. Clin. Endocrinol. Metab. 86 2001 2719 2723
10. F.H. Luyckx, and A.J. Scheen Le syndrome ḿtabolique:: comparaison des param̀tres biologiques dans diff́rentes d́finitions Immunoanal. Biol. Spec. 19 2004 188 194
11. H. Rosolova, J. Simon, O. Mayer Jr., J. Racek, T. Dierź, and D.W. Jacobsen Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy susjects Physiol. Res. 51 2002 93 98
12. J.B. Meigs, P.F. Jacques, J. Selhub, D.E. Sinser, D.M. Nathan, and N. Rifai Fasting plasma homocysteine levels in the insulin resistance syndrome. The Framingham offspring study Diabetes care 24 2001 1403 1410
13. W.H.H. Sheu, W.J. Lee, and Y.T. Chen Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects Am. J. Hypertens. 20 2000 14 20